Submitted for Publication: December 6, 2013; final revision received April 30, 2014; accepted May 6, 2014.
Published Online: August 20, 2014. doi:10.1001/jamapsychiatry.2014.1031.
Study concept and design: Singh, Howe, Reiss, Gotlib, Chang.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Singh, Kelley, Chang.
Critical revision of the manuscript for important intellectual content: Singh, Howe, Reiss, Gotlib, Chang.
Statistical analysis: Singh, Kelley, Gotlib.
Obtained funding: Singh.
Administrative, technical, or material support: All authors.
Study supervision: Singh, Reiss, Gotlib, Chang.
Conflict of Interest Disclosures: Drs Singh and Gotlib reported receiving research funding from the National Institute of Mental Health. Dr Reiss reported serving as a consultant for Novartis and receiving research funding from the National Institutes of Health. Dr Chang reported receiving research funding from GlaxoSmithKline, Merck, National Institute of Mental Health, and Brain and Behavior Research Foundation and serving as an unpaid consultant for GlaxoSmithKline, Eli Lilly and Company, Bristol-Myers Squibb, Merck, and Sunovion. No other disclosures were reported.
Funding/Support: This research was supported by grant MH085919 from the National Institute of Mental Health (Dr Singh).
Role of the Funder/Sponsor: The funding source had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Additional Contributions: Elizabeth Adams, MSN, Rosie Shoemaker, BA, Erica Marie Sanders, BA, and Jennifer Kallini, BS, assisted with assessment, recruitment, data collection, and data entry. Mss Adams, Shoemaker, and Sanders were paid research assistants funded by the grant from the National Institute of Mental Health.